15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 15 firms covering Equifax Inc, 11 rate it Buy or better, 4 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets are tightly clustered, $194.00 to $271.00, so the covering firms are broadly aligned. The average target of $223.40 sits 19% above the current $187.03. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $2.23 next quarter toward $10.17 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS15 ratings
Moderate Buy
Strong Buy00%
Buy1173%
Hold427%
Sell00%
Strong Sell00%
Based on 15 analysts giving stock ratings to Equifax Inc.
As of Jul, 11 of 15 firms rate EFX a Buy (4 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
EFX EPS & revenue forecast
EPS · NEXT QUARTER
$2.23
Range $2.13 – $2.39 · 19 analysts · +7% YoY
Next period, 19 analysts expect Equifax Inc to earn $2.23 a share (range $2.13 – $2.39), versus $2.09 a year earlier. Full-year consensus is $8.57, growing to $10.17 the year after.
REVENUE · NEXT QUARTER
$1.7B
Range $1.7B – $1.7B · 19 analysts · +10% YoY
Revenue is expected to reach $1.7B (range $1.7B – $1.7B), +9.8% year-over-year. Full-year consensus is $6.8B, rising to $7.4B next year.
Top analysts covering Equifax Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on EFX.
#1
Manav Patnaik
Barclays · Rank #113
Hold
$200.00+6.9% to target
Overall win rate
41%
+ Follow
#2
George Tong
Goldman Sachs · Rank #293
Hold
$182.00-2.7% to target
Overall win rate
33%
+ Follow
#3
Kyle Peterson
Needham · Rank #366
Buy
$245.00+31.0% to target
Overall win rate
25%
+ Follow
#4
Kevin Mcveigh
UBS
Buy
$220.00+17.6% to target
Coverage
—
+ Follow
#5
Ashish Sabadra
RBC Capital
Buy
$194.00+3.7% to target
Coverage
—
+ Follow
EFX stock forecast FAQ
What is EFX's average 12-month price target?+
The 10 analysts with a live target average $223.40 for Equifax Inc over the next 12 months, ranging from a $271.00 high to a $194.00 low.
Is EFX stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 15 analyst ratings, 11 are Buy or Strong Buy, 4 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for EFX?+
The Street-high target is $271.00 (Oppenheimer), and the Street-low is $194.00 (RBC Capital). The average of all 10 active targets is $223.40.
How many Wall Street analysts cover EFX?+
15 analysts have an active rating on Equifax Inc, and 10 firms carry a live 12-month price target.
Who is the most accurate analyst covering EFX?+
Among analysts who currently cover EFX, Manav Patnaik of Barclays has the strongest overall Quantellect track record (Rank #113). Their current call is Hold with a $200.00 target.
What is Equifax Inc's projected EPS for next quarter?+
The consensus estimate is $2.23 per share (range $2.13 – $2.39) across 19 analysts. Full-year EPS is projected at $8.57, rising to $10.17 the following year.
How much revenue is Equifax Inc expected to report next quarter?+
Consensus revenue is $1.7B (range $1.7B – $1.7B). Full-year revenue is projected at $6.8B, growing to $7.4B next year.
Have analysts been upgrading or downgrading EFX lately?+
As of Jul, 11 of 15 firms rate EFX a Buy (4 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their EFX calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
